Drug recall D-0484-2019
Product
Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 Manufactured by: lupin Limited Pithampur (M.P.) 454 775 India. NDC 68180-422-01
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.
Lots and codes
Lot Numbers: H705562, H705563, EXP. 11/2019; H800616, EXP. 01/2020
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 43,860 3ml bottles
- Distribution
- Product was distributed by 5 wholesalers, 6 drug chains, 4 mail order pharmacies and 1 mail order pharmacy/supermarket who may have further distribute the product throughout the United States.
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 1, 2019
- Terminated
- June 26, 2020
Related products
- Moxifloxacin – drug information
- NDC 68180-422 Moxifloxacin · Moxifloxacin Hydrochloride Monohydrate 5 mg/mL · Lupin Pharmaceuticals, Inc.